EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹2,668 Cr | ₹3,210 Cr | ₹3,019 Cr | ₹2,965 Cr | ₹3,408 Cr |
What is the latest Total Current Liabilities ratio of EMCURE PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹2,668 Cr |
| Mar2024 | ₹3,210 Cr |
| Mar2023 | ₹3,019 Cr |
| Mar2022 | ₹2,965 Cr |
| Mar2021 | ₹3,408 Cr |
How is Total Current Liabilities of EMCURE PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,668 Cr | -16.89 | |
| Mar2024 | ₹3,210 Cr | 6.34 | |
| Mar2023 | ₹3,019 Cr | 1.83 | |
| Mar2022 | ₹2,965 Cr | -13.01 | |
| Mar2021 | ₹3,408 Cr | - | |
Compare Total Current Liabilities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹28,126.2 Cr | -0.5% | -2.8% | 24.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,439.0 Cr | 5.7% | -3.3% | -2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,903.0 Cr | 1.6% | -7.6% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,466.0 Cr | -0.5% | 0.9% | 23.6% | Stock Analytics | |
| CIPLA | ₹107,653.0 Cr | 0.5% | -12.9% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,924.0 Cr | 5.3% | -0.9% | 1.9% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -0.5% |
-2.8% |
24.9% |
| SENSEX | 1.3% |
-2.5% |
8.5% |
You may also like the below Video Courses